Machine learning predictions based on historical earnings data and price patterns
1-Day Prediction
+3.38%
$121.61
100% positive prob.
5-Day Prediction
+6.74%
$125.56
100% positive prob.
20-Day Prediction
+8.71%
$127.87
95% positive prob.
SEC 8-K filings with transcript text
Feb 23, 2026 · 100% conf.
1D
+3.38%
$121.61
5D
+6.74%
$125.56
20D
+8.71%
$127.87
adus20260220_8k.htm
false 0001468328
0001468328
2026-02-23 2026-02-23
PURSUANT TO SECTION 13 OR 15(d)
Date of Report (Date of earliest event reported): February 23, 2026
(Exact name of registrant as specified in its charter)
Delaware
001-34504
20-5340172
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
6303 Cowboys Way, Suite 600
Frisco, Texas
75034
(Address of principal executive offices)
(Zip Code)
(469) 535-8200
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d- 2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e- 4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading
Symbol(s)
Name of each exchange
on which registered
Common Stock, $0.001 par value per share
The Nasdaq Stock Market, LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company. ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02
Results of Operations and Financial Condition.
On February 23, 2026, Addus HomeCare Corporation (the “Company”) issued a press release (the “Press Release”) announcing, among other matters, the Company’s results of operations for the fiscal quarter and year ended December 31, 2025. A copy of the Press Release is furnished herewith as Exhibit 99.1 to this report and is incorporated herein by reference.
Item 7.01.
Regulation FD Disclosure
On February 23, 2026, the Company issued the Press Release, announcing, among other matters, its results of operations for the fiscal quarter and year ended December 31, 2025, the text of which is set forth as Exhibit 99.1.
Item 9.01
Financial Statements and Exhibits.
(d) Exhibits:
Exhibit
No.
Description
99.1
Press Release of Addus HomeCare Corporation dated February 23, 2026.
104
Cover Page Interactive Data File (embedded within Inline XBRL document).
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: February 23, 2026
By:
/s/ Brian Poff
Brian Poff
Chief Financial Officer
Nov 3, 2025
adus20251103_8k.htm
false 0001468328
0001468328
2025-11-03 2025-11-03
PURSUANT TO SECTION 13 OR 15(d)
Date of Report (Date of earliest event reported): November 3, 2025
(Exact name of registrant as specified in its charter)
Delaware
001-34504
20-5340172
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
6303 Cowboys Way, Suite 600
Frisco, Texas
75034
(Address of principal executive offices)
(Zip Code)
(469) 535-8200
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d- 2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e- 4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading
Symbol(s)
Name of each exchange
on which registered
Common Stock, $0.001 par value per share
The Nasdaq Stock Market, LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company. ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02
Results of Operations and Financial Condition.
On November 3, 2025, Addus HomeCare Corporation (the “Company”) issued a press release (the “Press Release”) announcing, among other matters, the Company’s results of operations for the fiscal quarter ended September 30, 2025. A copy of the Press Release is furnished herewith as Exhibit 99.1 to this report and is incorporated herein by reference.
Item 7.01
Regulation FD Disclosure
On November 3, 2025, the Company issued the Press Release, announcing, among other matters, its results of operations for the fiscal quarter ended September 30, 2025, the text of which is set forth as Exhibit 99.1.
Item 9.01
Financial Statements and Exhibits.
(d) Exhibits:
Exhibit
No.
Description
99.1
Press Release of Addus HomeCare Corporation dated November 3, 2025.
104
Cover Page Interactive Data File (embedded within Inline XBRL document).
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: November 3, 2025
By:
/s/ Brian Poff
Brian Poff
Chief Financial Officer
Aug 4, 2025
adus20250801_8k.htm
false 0001468328
0001468328
2025-08-04 2025-08-04
PURSUANT TO SECTION 13 OR 15(d)
Date of Report (Date of earliest event reported): August 4, 2025
(Exact name of registrant as specified in its charter)
Delaware
001-34504
20-5340172
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
6303 Cowboys Way, Suite 600
Frisco, Texas
75034
(Address of principal executive offices)
(Zip Code)
(469) 535-8200
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d- 2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e- 4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading
Symbol(s)
Name of each exchange
on which registered
Common Stock, $0.001 par value per share
The Nasdaq Stock Market, LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company. ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02
Results of Operations and Financial Condition.
On August 4, 2025, Addus HomeCare Corporation (the “Company”) issued a press release (the “Press Release”) announcing, among other matters, the Company’s results of operations for the fiscal quarter ended June 30, 2025. A copy of the Press Release is furnished herewith as Exhibit 99.1 to this report and is incorporated herein by reference.
Item 7.01.
Regulation FD Disclosure
On August 4, 2025, the Company issued the Press Release, announcing, among other matters, its results of operations for the fiscal quarter ended June 30, 2025, the text of which is set forth as Exhibit 99.1.
Item 9.01
Financial Statements and Exhibits.
(d) Exhibits:
Exhibit
No.
Description
99.1
Press Release of Addus HomeCare Corporation dated August 4, 2025.
104
Cover Page Interactive Data File (embedded within Inline XBRL document).
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: August 4, 2025
By:
/s/ Brian Poff
Brian Poff
Chief Financial Officer
This page provides Addus HomeCare Corporation (ADUS) earnings call transcripts from SEC 8-K filings along with AI-powered predictions for post-earnings price movements. Our machine learning models analyze historical earnings data, pre-earnings price patterns, volume changes, and volatility to predict 1-day, 5-day, and 20-day returns after each earnings release.
Earnings transcripts are sourced directly from SEC EDGAR filings. Predictions are generated using gradient boosting models trained on ADUS's historical earnings reactions. All predicted returns are shown as percentages, and predicted prices are calculated from the closing price at the time of prediction. Past performance does not guarantee future results.